We are live on
!
Find out more
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX
Delisted
DBTX was delisted on the 22nd of September, 2023.
38 hedge funds and large institutions have $46.7M invested in Decibel Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more capital invested
Capital invested by funds: $35.8M → $46.7M (+$10.9M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
3% less funds holding
Funds holding: 39 → 38 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
38
Holders Change
-1
Holders Change %
-2.56%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
10
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$655K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$145K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$51.9K |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$51.5K |
| 5 |
Bank of New York Mellon
New York
|
+$44.1K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$3.66M |
| 2 |
Millennium Management
New York
|
-$838K |
| 3 |
Barclays
London,
United Kingdom
|
-$787K |
| 4 |
NM
Newtyn Management
New York
|
-$55.9K |
| 5 |
E
Ergoteles
New York
|
-$48.1K |
